|
ASH/FDA Workshop on
Clinical Endpoints in Acute Leukemia
Panel Members
·
FDA Representatives:
o
Richard Pazdur, MD
US Food and Drug Administration
o
Patricia Keegan, MD
US Food and Drug Administration
·
ASH Liaison:
o
Stanley L. Schrier, MD
Stanford University School of Medicine
·
NIH Representatives:
o
Malcolm Smith, MD, PhD
National Cancer Institute
o
Thomas A. Davis, MD
National Cancer Institute
·
Industry Representative:
o
Martine George, MD
Johnson & Johnson Pharmaceutical
·
Pediatric Acute Lymphoid Leukemia
o
Chair: Sharon B. Murphy, MD
Children's Cancer Research Institute
The University of Texas Health Science Center at San Antonio
o
Joseph Gootenberg, MD
US Food and Drug Administration
o
William L. Carroll, MD
New York University School of Medicine
o
Malcolm Smith, MD, PhD
National Cancer Institute
·
Adult Acute Lymphoblastic Leukemia
o
Chair: Richard A. Larson, MD
The University of Chicago
o
Ann Farrell, MD
US Food and Drug Administration
o
Susan O'Brien, MD
MD Anderson Cancer Center
o
Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center
·
Pediatric Acute Myeloid Leukemia
o
Chair: Franklin O. Smith, MD
University of Cincinnati College of Medicine
o
Patricia Dinndorf, MD
US Food and Drug Administration
o
Philip Breitfeld, MD
Duke University Medical Center
o
Robert J. Arceci, MD, PhD
Johns Hopkins Oncology Center
·
Adult Acute Myeloid Leukemia
o
Chair: Martin S. Tallman, MD
Northwestern University Medical School
o
Nancy Scher, MD
US Food and Drug Administration
o
Stephen J. Forman, MD
City of Hope National Medical Center
o
Elihu H. Estey, MD
M.D. Anderson Cancer Center
o
David Harrington, PhD
Dana Farber Cancer Institute
·
Acute Leukemia in the Elderly
o
Chair: Frederick R. Appelbaum, MD
Fred Hutchinson Cancer Research Center
o
Daniel Rosenblum, MD
US Food and Drug Administration
o
Richard M. Stone, MD
Dana-Farber Cancer Institute
Additional Workshop Subcommittee Members Not
Serving as Panelists
·
Pediatric Acute Lymphoid Leukemia
o
Stephen L. George, PhD
Duke University Medical Center
o
Naomi Winick, MD
University of Texas Southwestern Medical Center
o
William E Evans, PharmD
St Jude Children's Research Hospital
o
Susan L. Weiner, PhD
Children's Cause for Cancer Advocacy
·
Adult Acute Lymphoblastic Leukemia
o
Stephen L. George, PhD
Duke University Medical Center
o
James W. Vardiman, MD
University of Chicago
o
Charles Linker, MD
University of California
·
Pediatric Acute Myeloid Leukemia
o
Donald Small, MD, PhD
Johns Hopkins Hospital
o
Todd Alonzo, PhD
University of Southern California
o
Louis Leone, Esq.
Children's Oncology Group
·
Adult Acute Myeloid Leukemia
o
Cheryl L. Willman, MD
University of New Mexico
o
Elisabeth Paietta, PhD
Our Lady of Mercy Medical Center
o
Ernest Beutler, MD
The Scripps Research Institute
·
Acute Leukemia in the Elderly
o
Kenneth J. Kopecky, PhD
Southwest Oncology Group Statistical Center
o
James W. Vardiman, MD
University of Chicago
o
Stephanie Lee, MD, MPH
Dana-Farber Cancer Institute
o
Susan Stewart
BMT InfoNet
o
Wolfgang Hiddemann, PhD, MD
University Hospital Grosshadern
Ludwig-Maximilians University
Back to Top 
Back to Cancer Endpoints
Date created: September 21, 2005  |
